Recently a manuscript has been published that uses different endpoints for long-term cultivation of human PCLS, focusing on PCLS as a “high-throughput, ex vivo system for evaluating the safety, and potentially immunogenicity, of vaccines and pharmaceuticals” [19].
![[This page as RDF]](http://data.gesis.org/somesci/static/rdf-icon.gif){kind=icon}